DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Research

September 19, 2023
Urgent Action: Paid Opportunity for People with Mets Disease to the Brain

People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.

Read More
September 6, 2023
More Great News For The Fight Against GBM!

Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.

Read More
September 6, 2023
Elevate the Patient Voice in Mets Disease to the Brain

People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.

Read More
September 2, 2023
rGBM Study

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

Read More
September 2, 2023
PROSPECT PCNSL Study

PROSPECT is an open-label, Phase II study evaluating the efficacy, safety, and pharmacokinetics of an oral medicine called Tirabrutinib.

Read More
August 24, 2023
Paid Survey for GBM Patients

People living with glioblastoma multiforme (GBM) are invited to participate in this online survey about their experience.

Read More
August 11, 2023
SNO/ASCO CNS Cancer Conference

The End Brain Cancer Initiative team is proud to be attending the 2023 SNO/ASCO CNS Cancer Conference.

Read More
August 10, 2023
Glioblastoma Study

People living with glioblastoma multiforme (GBM) are invited to participate in a paid online survey about their experience.

Read More
July 24, 2023
Seeking a Clinical Research Nurse

EBCI is seeking a clinical research nurse to join us in our mission to ensure the best treatment for brain cancer patients.

Read More
July 8, 2023
rGBM Study: Share Your Experience and Shape Future Treatments for GBM

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

Read More
July 7, 2023
Recruiting Now for Patients with Recurrent GBM

We are looking to interview patients, and their caregivers, who are living with recurrent glioblastoma (GBM).

Read More
May 26, 2023
Nivolumab Clinical Trial

National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.

Read More
1 2 3

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram